The upregulation of Sam68 expression and its subsequent impact on proliferation and tumorigenicity has been reported in several cancers, such as breast [71, 72], prostate [73], cervical [25], gastric [74], non-small cell lung [75] and renal tumors [26]. The gene discussed is KHDRBS1; the disease is cancer.